Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Han Feng

Showing results (321-330 of 382) with videos related to

Pageof 39
Sort By:
Pharmaceuticals (Basel, Switzerland)|June 1, 2023
P2Y12 Inhibitor Monotherapy versus Conventional Dual Antiplatelet Therapy in Patients with Acute Coronary Syndrome after Percutaneous Coronary Intervention: A Meta-AnalysisWen-Han Feng, Yong-Chieh Chang, Yi-Hsiung Lin, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|June 27, 2026
Hsa_circ_0003258 drives serine biosynthesis and docetaxel resistance in prostate cancer by enhancing IGF2BP3-mediated PSAT1 mRNA stabilityShengdong Ge, Xiaofeng Liu, Xianzi Zeng, et al.
International Journal of Nanomedicine|January 15, 2019
Antitumor activity of the bioreductive prodrug 3-(2-nitrophenyl) propionic acid-paclitaxel nanoparticles (NPPA-PTX NPs) on MDA-MB-231 cells: in vitro and in vivoXiao-Chuan Duan, Xin Yao, Shuang Zhang, et al.
Frontiers in Microbiology|August 29, 2022
Development and evaluation of a rapid RPA/CRISPR-based detection of <i>Francisella tularensis</i>Jian-Hao Xu, Lin Kang, Bing Yuan, et al.
Drug Delivery|April 19, 2021
The synergistic antitumor activity of 3-(2-nitrophenyl) propionic acid-paclitaxel nanoparticles (NPPA-PTX NPs) and anti-PD-L1 antibody inducing immunogenic cell deathXiao-Chuan Duan, Li-Yuan Peng, Xin Yao, et al.
Journal of Cardiovascular Electrophysiology|October 22, 2025
Catheter Ablation Is Associated With a Decrease in Major Adverse Cardiovascular Events and All-Cause Mortality in Patients With Atrial Fibrillation and Obstructive Sleep ApneaGhassan Bidaoui, Christian Massad, Joe Abi-Rached, et al.
International Journal of General Medicine|May 9, 2024
Optimal Glycated Hemoglobin Cutoff for Diagnosis of Diabetes and Prediabetes in Chinese Breast Cancer WomenXin-Yu Liang, Li-Yuan Mu, Lei Hu, et al.
Diabetes|November 30, 2021
MG53 E3 Ligase-Dead Mutant Protects Diabetic Hearts From Acute Ischemic/Reperfusion Injury and Ameliorates Diet-Induced Cardiometabolic DamageHan Feng, Hao Shen, Matthew J Robeson, et al.
Antimicrobial Agents and Chemotherapy|February 26, 2025
Optimizing phage therapy for carbapenem-resistant <i>Enterobacter cloacae</i> bacteremia: insights into dose and timingShi-Yong Fu, Xiu-Zhen Chen, Peng-Cheng Yi, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|May 6, 2022
Alisol B 23-acetate adjusts bile acid metabolisim via hepatic FXR-BSEP signaling activation to alleviate atherosclerosisYu Fu, Han Feng, Xue Ding, et al.
Pageof 39

Showing results (321-330 of 382) with videos related to

Sort By:
Pageof 39
Pharmaceuticals (Basel, Switzerland)|June 1, 2023
P2Y12 Inhibitor Monotherapy versus Conventional Dual Antiplatelet Therapy in Patients with Acute Coronary Syndrome after Percutaneous Coronary Intervention: A Meta-AnalysisWen-Han Feng, Yong-Chieh Chang, Yi-Hsiung Lin, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|June 27, 2026
Hsa_circ_0003258 drives serine biosynthesis and docetaxel resistance in prostate cancer by enhancing IGF2BP3-mediated PSAT1 mRNA stabilityShengdong Ge, Xiaofeng Liu, Xianzi Zeng, et al.
International Journal of Nanomedicine|January 15, 2019
Antitumor activity of the bioreductive prodrug 3-(2-nitrophenyl) propionic acid-paclitaxel nanoparticles (NPPA-PTX NPs) on MDA-MB-231 cells: in vitro and in vivoXiao-Chuan Duan, Xin Yao, Shuang Zhang, et al.
Frontiers in Microbiology|August 29, 2022
Development and evaluation of a rapid RPA/CRISPR-based detection of <i>Francisella tularensis</i>Jian-Hao Xu, Lin Kang, Bing Yuan, et al.
Drug Delivery|April 19, 2021
The synergistic antitumor activity of 3-(2-nitrophenyl) propionic acid-paclitaxel nanoparticles (NPPA-PTX NPs) and anti-PD-L1 antibody inducing immunogenic cell deathXiao-Chuan Duan, Li-Yuan Peng, Xin Yao, et al.
Journal of Cardiovascular Electrophysiology|October 22, 2025
Catheter Ablation Is Associated With a Decrease in Major Adverse Cardiovascular Events and All-Cause Mortality in Patients With Atrial Fibrillation and Obstructive Sleep ApneaGhassan Bidaoui, Christian Massad, Joe Abi-Rached, et al.
International Journal of General Medicine|May 9, 2024
Optimal Glycated Hemoglobin Cutoff for Diagnosis of Diabetes and Prediabetes in Chinese Breast Cancer WomenXin-Yu Liang, Li-Yuan Mu, Lei Hu, et al.
Diabetes|November 30, 2021
MG53 E3 Ligase-Dead Mutant Protects Diabetic Hearts From Acute Ischemic/Reperfusion Injury and Ameliorates Diet-Induced Cardiometabolic DamageHan Feng, Hao Shen, Matthew J Robeson, et al.
Antimicrobial Agents and Chemotherapy|February 26, 2025
Optimizing phage therapy for carbapenem-resistant <i>Enterobacter cloacae</i> bacteremia: insights into dose and timingShi-Yong Fu, Xiu-Zhen Chen, Peng-Cheng Yi, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|May 6, 2022
Alisol B 23-acetate adjusts bile acid metabolisim via hepatic FXR-BSEP signaling activation to alleviate atherosclerosisYu Fu, Han Feng, Xue Ding, et al.
Pageof 39